perphenazine and quetiapine fumarate

perphenazine has been researched along with quetiapine fumarate in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	18 (47.37)	29.6817
2010's	17 (44.74)	24.3611
2020's	3 (7.89)	2.80

Authors

Authors	Studies
Lieberman, JA; Stroup, TS	1
Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lebowitz, BD; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS	1
Delisi, LE; Nasrallah, HA	1
Luchins, DJ	1
Hsiao, JK; Lieberman, JA	1
Banks, SM; Pandiani, JA	1
Anghelescu, IG; Dettling, M	1
Belz, I; Capuano, GA; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, AL; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Capuano, G; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; McGee, MF; Perkins, DO; Reimherr, F; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Bilder, RM; Capuano, G; Davis, CE; Davis, SM; Gold, JM; Green, MF; Harvey, PD; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Palmer, BW; Perkins, DO; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Campbell, DB; Ebert, PJ; Levitt, P; Lieberman, J; Skelly, T; Stroup, TS; Sullivan, PF	1
Bick, P; Castle, D; Knoesen, N	1
Canive, JM; Davis, SM; Hsiao, JK; Khan, A; Lieberman, JA; McEvoy, JP; McGee, M; Miller, DD; Reimherr, F; Stroup, TS; Swanson, JW; Swartz, MS; Wagner, HR	1
Allingham, B; Citrome, L; Jaffe, A; Levine, J; Martello, D	1
Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Daumit, GL; Davis, SM; Davis, VG; Goff, DC; Hsiao, J; Lieberman, JA; McEvoy, JP; Meyer, JM; Nasrallah, HA; Stroup, TS; Swartz, MS	1
Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, AL; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Haukka, J; Klaukka, T; Lönnqvist, J; Niskanen, L; Tanskanen, A; Tiihonen, J; Wahlbeck, K	1
Aberg, K; Adkins, DE; Lieberman, JA; McClay, JL; Perkins, DO; Stroup, S; Sullivan, PF; van den Oord, EJ; Vladimirov, VI	1
Cohen, D; Correll, CU; De Hert, M	1
Campbell, EC; Caroff, SN; Chakos, MH; Davis, SM; Davis, VG; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, DD; Riggio, S; Rosenheck, RA; Saltz, BL; Stroup, TS; Swartz, MS	1
Fitzmaurice, GM; Horton, NJ; Laird, NM; Lipsitz, SR; Normand, SL; Yoon, FB	1
Dudova, I; Hrdlicka, M; Urbanek, T; Zedkova, I	1
Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A	1
Hermes, E; Rosenheck, R	1
Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J	1
Lin, H; Rosenheck, R	1
Cao, B; Hou, R; Jian, J; Mi, G; Qiu, H; Tang, M; Wang, M	1
Brennan, MD; Ramsey, TL	1
Lin, H; McEvoy, J; Mohamed, S; Rosenheck, RA; Stroup, S; Swartz, M	1
Alphs, L; Correll, CU; Kim, E; Mao, L; Starr, HL	1
Siegfried, N; Stein, DJ; Temmingh, HS; Williams, T	1
Hoti, F; Lähteenvuo, M; Taipale, H; Tanskanen, A; Tiihonen, J; Vattulainen, P; Vieta, E	1
Bellavia, A; Centorrino, F; Fitzmaurice, G; Jackson, JW; Valeri, L	1
Bareis, N; Stroup, TS	1
Correll, CU; DiPetrillo, L; Jiang, Y; Liu, Y; Pathak, S; Todtenkopf, MS	1
Christensen, J; Dreier, JW; Liu, X; Munk-Olsen, T; Trabjerg, BB	1
Chen, Q; Coid, J; Deng, W; Guo, W; Li, K; Li, L; Li, T; Lu, T; Lv, L; Ma, X; Tan, L; Tan, Q; Tao, S; Wang, C; Wang, L; Wang, Q; Wei, W; Yan, H; Yang, F; Yang, G; Yang, J; Yue, W; Zhang, D; Zhang, F; Zhang, H; Zhang, Y; Zhao, L	1

Reviews

1 review(s) available for perphenazine and quetiapine fumarate

Article	Year
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. The Cochrane database of systematic reviews, 2018, Jan-22, Volume: 1 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diagnosis, Dual (Psychiatry); Humans; Mental Disorders; Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Substance-Related Disorders; Thiazoles	2018

Article

Year

Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.

The Cochrane database of systematic reviews, 2018, Jan-22, Volume: 1

Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diagnosis, Dual (Psychiatry); Humans; Mental Disorders; Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Substance-Related Disorders; Thiazoles

2018

Trials

22 trial(s) available for perphenazine and quetiapine fumarate

Article	Year
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England journal of medicine, 2005, Sep-22, Volume: 353, Issue:12 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Female; Humans; Lipids; Male; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain	2005
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. The American journal of psychiatry, 2007, Volume: 164, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Perphenazine; Proportional Hazards Models; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2007
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. The American journal of psychiatry, 2007, Volume: 164, Issue:3 Topics: Adaptation, Psychological; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Follow-Up Studies; Health Status; Humans; National Institute of Mental Health (U.S.); Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thiazoles; Treatment Outcome; United States	2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of general psychiatry, 2007, Volume: 64, Issue:6 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Cohort Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome	2007
Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia. Biological psychiatry, 2008, Jan-01, Volume: 63, Issue:1 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Dibenzothiazepines; Ethnicity; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Perphenazine; Pharmacogenetics; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; RGS Proteins; Schizophrenia; Treatment Outcome	2008
Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2007, Volume: 15, Issue:6 Topics: Antipsychotic Agents; Australia; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Humans; Olanzapine; Perphenazine; Piperazines; Psychiatry; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors	2007
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study. Schizophrenia research, 2008, Volume: 100, Issue:1-3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Comorbidity; Dibenzothiazepines; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Olanzapine; Patient Dropouts; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders; Time Factors; Treatment Outcome; Treatment Refusal	2008
What CATIE found: results from the schizophrenia trial. Psychiatric services (Washington, D.C.), 2008, Volume: 59, Issue:5 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychology; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles	2008
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. Schizophrenia research, 2008, Volume: 103, Issue:1-3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides	2008
Results of phase 3 of the CATIE schizophrenia trial. Schizophrenia research, 2009, Volume: 107, Issue:1 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Young Adult	2009
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics. Molecular psychiatry, 2011, Volume: 16, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Chromosomes, Human, Pair 4; Dibenzothiazepines; Double-Blind Method; Follow-Up Studies; Genome-Wide Association Study; Humans; Olanzapine; Perphenazine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2011
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Movement Disorders; Olanzapine; Perphenazine; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Thiazoles; Treatment Outcome	2011
Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:9 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Olanzapine; Patient Acceptance of Health Care; Patient Dropouts; Patient Participation; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Characteristics	2012
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. CNS spectrums, 2014, Volume: 19, Issue:5 Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles	2014
Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic schizophrenia. The Journal of nervous and mental disease, 2014, Volume: 202, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Sample Size; Schizophrenia; Thiazoles; Treatment Outcome	2014
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial. Schizophrenia research, 2014, Volume: 160, Issue:1-3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Dibenzothiazepines; Female; Genotyping Techniques; Glucagon-Like Peptide-1 Receptor; Haplotypes; Humans; Male; Models, Genetic; Olanzapine; Perphenazine; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Receptors, Glucagon; Regression Analysis; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain; White People	2014
Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia. The Journal of nervous and mental disease, 2015, Volume: 203, Issue:7 Topics: Adolescent; Adult; Aged; Alcoholism; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Comorbidity; Cross-Sectional Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Substance-Related Disorders; Thiazoles; Young Adult	2015
Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia. CNS spectrums, 2016, Volume: 21, Issue:6 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Delayed-Action Preparations; Female; Haloperidol; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Perphenazine; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome	2016
The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial. Schizophrenia research, 2019, Volume: 206 Topics: Adult; Antipsychotic Agents; Body-Weight Trajectory; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain	2019
Examination of heterogeneity in treatment response to antipsychotic medications. Schizophrenia research, 2019, Volume: 211 Topics: Adult; Antipsychotic Agents; Deprescriptions; Female; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Mental Status and Dementia Tests; Olanzapine; Perphenazine; Proportional Hazards Models; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2019
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study. The Journal of clinical psychiatry, 2020, 03-17, Volume: 81, Issue:2 Topics: Adult; Alcoholism; Antipsychotic Agents; Comorbidity; Female; Hospitalization; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Symptom Flare Up; Thiazoles; Time Factors	2020
The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia. Current neuropharmacology, 2024, Volume: 22, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Glucose; Haloperidol; Humans; Inflammation; Olanzapine; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia	2024

Other Studies

15 other study(ies) available for perphenazine and quetiapine fumarate

Article	Year
Schizophrenia, VI: Treatments. The American journal of psychiatry, 2003, Volume: 160, Issue:10 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Perphenazine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2003
The CATIE schizophrenia effectiveness trial. Schizophrenia research, 2005, Dec-01, Volume: 80, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Drug Tolerance; Humans; Olanzapine; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome	2005
Interpreting the results of the CATIE study. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:1 Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; National Institute of Mental Health (U.S.); Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; United States	2006
Interpreting the results of the CATIE study. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:1 Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2006
Interpreting the results of the CATIE study. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:1 Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome	2006
Antipsychotic drugs and schizophrenia. The New England journal of medicine, 2006, Jan-19, Volume: 354, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles	2006
Did CATIE influence antipsychotic use? Psychiatric services (Washington, D.C.), 2008, Volume: 59, Issue:5 Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy; Haloperidol; Humans; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles	2008
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (London, England), 2009, Aug-22, Volume: 374, Issue:9690 Topics: Adult; Age Distribution; Aged; Antipsychotic Agents; Case-Control Studies; Cause of Death; Clozapine; Dibenzothiazepines; Drug Utilization; Female; Finland; Follow-Up Studies; Health Status Disparities; Humans; Life Expectancy; Male; Middle Aged; Patient Readmission; Perphenazine; Proportional Hazards Models; Quetiapine Fumarate; Registries; Risk Factors; Schizophrenia; Sex Distribution; Time Factors	2009
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia research, 2010, Volume: 117, Issue:1 Topics: Adult; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Female; Finland; Haloperidol; Humans; Male; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Suicide; Survival Rate	2010
Alternative methods for testing treatment effects on the basis of multiple outcomes: simulation and case study. Statistics in medicine, 2011, Jul-20, Volume: 30, Issue:16 Topics: Antipsychotic Agents; Biostatistics; Clinical Trials as Topic; Dibenzothiazepines; Humans; Likelihood Functions; Linear Models; Metabolic Syndrome; Models, Statistical; Multivariate Analysis; Outcome Assessment, Health Care; Perphenazine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Schizophrenia; Treatment Outcome	2011
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses. Neuro endocrinology letters, 2011, Volume: 32, Issue:5 Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medical Records; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome	2011
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs. Medical science monitor : international medical journal of experimental and clinical research, 2012, Volume: 18, Issue:1 Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride	2012
Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study. Human psychopharmacology, 2014, Volume: 29, Issue:2 Topics: Adult; Alkaline Phosphatase; Antipsychotic Agents; Aripiprazole; Bone Density; Chlorpromazine; Clozapine; Dibenzothiazepines; Estrogens; Female; Humans; Male; Middle Aged; Osteoporosis; Perphenazine; Piperazines; Prolactin; Prospective Studies; Quetiapine Fumarate; Quinolones; Risk Factors; Schizophrenia; Sulpiride	2014
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder. JAMA psychiatry, 2018, 04-01, Volume: 75, Issue:4 Topics: Administration, Oral; Adult; Bipolar Disorder; Cohort Studies; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; Humans; Injections, Intramuscular; Lithium Carbonate; Male; Middle Aged; Patient Readmission; Perphenazine; Prospective Studies; Psychotropic Drugs; Quetiapine Fumarate; Risk; Risperidone; Treatment Outcome	2018
Association of Maternal Antipsychotic Prescription During Pregnancy With Standardized Test Scores of Schoolchildren in Denmark. JAMA internal medicine, 2022, 10-01, Volume: 182, Issue:10 Topics: Antipsychotic Agents; Child; Clopenthixol; Cohort Studies; Denmark; Female; Flupenthixol; Humans; Male; Methotrimeprazine; Olanzapine; Perphenazine; Pregnancy; Prescriptions; Quetiapine Fumarate	2022